TriangleHEALTH PROFESSIONAL · SOURCE READING
Acute Myeloid Leukemia (AML)
Source: Childhood Cancer Genomics (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 30, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Leukemias
Continue within this section
Cytogenetic/molecular features of AML →Abnormalities associated with a favorable prognosis →Cytogenetic abnormality associated with a variable prognosis: KMT2A (MLL) gene rearrangements →Cytogenetic/molecular abnormalities associated with an unfavorable prognosis →Additional cytogenetic/molecular abnormalities that may have prognostic significance →
Preserved source evidence · Independent clinical review pending · Not medical advice